Groupama Asset Managment lifted its stake in shares of Danaher Corporation (NYSE:DHR – Free Report) by 22.6% in the 4th quarter, Holdings Channel.com reports. The firm owned 54,461 shares of the conglomerate’s stock after buying an additional 10,027 shares during the quarter. Groupama Asset Managment’s holdings in Danaher were worth $12,374,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other hedge funds and other institutional investors have also recently bought and sold shares of the company. JPL Wealth Management LLC acquired a new position in Danaher in the 3rd quarter valued at $25,000. Elevated Capital Advisors LLC acquired a new stake in shares of Danaher in the 4th quarter worth $26,000. WFA of San Diego LLC acquired a new stake in shares of Danaher in the 2nd quarter worth $26,000. ANTIPODES PARTNERS Ltd purchased a new stake in shares of Danaher in the third quarter valued at about $27,000. Finally, Hilton Head Capital Partners LLC purchased a new stake in shares of Danaher in the fourth quarter valued at about $27,000. 79.05% of the stock is currently owned by hedge funds and other institutional investors.
Analyst Upgrades and Downgrades
Several research firms recently issued reports on DHR. Jefferies Financial Group reissued a “buy” rating and set a $245.00 price target on shares of Danaher in a report on Tuesday, April 21st. Rothschild & Co Redburn set a $205.00 price objective on Danaher in a report on Friday, April 17th. The Goldman Sachs Group dropped their target price on Danaher from $265.00 to $230.00 and set a “buy” rating on the stock in a research report on Monday, April 13th. Weiss Ratings reissued a “hold (c)” rating on shares of Danaher in a research note on Friday, March 27th. Finally, Evercore raised their price target on Danaher from $225.00 to $232.00 and gave the company an “outperform” rating in a report on Tuesday, April 21st. One investment analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and five have given a Hold rating to the stock. Based on data from MarketBeat.com, Danaher currently has an average rating of “Moderate Buy” and an average target price of $233.61.
Danaher Stock Performance
Shares of DHR opened at $177.74 on Friday. The company has a quick ratio of 1.52, a current ratio of 1.87 and a debt-to-equity ratio of 0.33. Danaher Corporation has a 52-week low of $160.93 and a 52-week high of $242.80. The company has a 50-day simple moving average of $179.99 and a 200-day simple moving average of $203.25. The company has a market capitalization of $125.80 billion, a PE ratio of 34.38, a P/E/G ratio of 2.27 and a beta of 0.81.
Danaher (NYSE:DHR – Get Free Report) last released its quarterly earnings data on Monday, April 20th. The conglomerate reported $2.06 EPS for the quarter, topping analysts’ consensus estimates of $1.94 by $0.12. Danaher had a net margin of 14.89% and a return on equity of 10.91%. The firm had revenue of $5.95 billion for the quarter, compared to the consensus estimate of $6 billion. During the same quarter in the previous year, the firm earned $1.88 earnings per share. The firm’s revenue was up 3.7% on a year-over-year basis. Equities research analysts predict that Danaher Corporation will post 8.45 earnings per share for the current fiscal year.
Danaher Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Friday, June 26th will be given a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a dividend yield of 0.9%. The ex-dividend date is Friday, June 26th. Danaher’s dividend payout ratio (DPR) is presently 30.95%.
About Danaher
Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.
Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.
Featured Articles
- Five stocks we like better than Danaher
- Credo Technologies Accelerates AI—Its Stock Price Will Follow
- Qualcomm Goes All-In: The $10B Bet to Crush NVIDIA
- Jabil Just Gave Investors a Stronger Reason to Buy the Dip
- CarMax In Reverse? Why You Should Buy Now Before the Big Catalysts Emerge
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.
